Table 7. Spirometric Reference Values Recommended in Spain. Values corresponding to r 2. Table 8. Classification of the Severity of Airflow Limitation. Flow-volume curve patterns suggestive of upper airway obstruction. The FEV 1 should be reported as a percentage of the patient's predicted value. The acceptability of the manoeuvre should be automated and should show repeatability messages.
Appendix 1. Suggested list of spirometric variables for recording. Appendix 2. In this respect, standard ISO ; establishes that for the validation of a spirometer, it should be subjected to tests with different pressure and humidity levels, mimicking the different situations in which it may be used.
Palenciano Ballesteros, J. Roca Torrent. Ferguson, P. Enright, A. Buist, M. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest, , pp. Neas, J. Pulmonary function levels as predictors of mortality in a national sample of US adults.
Am J Epidemiol, , pp. Schunemann, J. Dorn, B. Grant, W. Winkelstein Jr. Pulmonary function is a long-term predictor of mortality in the general population: year follow-up of the Buffalo Health Study. Chyou, L. White, K. Yano, D. Sharp, C. Burchfiel, R. Chen, et al. Pulmonary function measures as predictors and correlates of cognitive functioning in later life.
Quanjer, G. Tammeling, J. Cotes, O. Pedersen, R. Peslin, J. Eur Respir J, 6 , pp. Standardization of spirometry, Update. N Engl J Med, , pp. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, et al. Eur Respir J, 26 , pp. Arch Bronconeumol, 48 , pp. Statement on respiratory mechanics in infants: physiologic evaluation in health and disease.
Kanengiser, A. Forced espiratory manoeuvres in children aged 3—5 years. Pediatr Pulmonol, 18 , pp. An update on contraindications for lung function testing. Thorax, 66 , pp. Contraindications for use of spirometry. Respir Care, 41 , pp.
Surv Ophthalmol, 39 , pp. Jing, T. Huang, W. Cui, F. Xu, H. A metaanalysis. Aurora, J. Stocks, C. Oliver, C. Saunders, R. Castle, G. Chaziparasidis, et al. Quality control for spirometry in preschool-children with and without lung disease. Bertley, L. Chau, K. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiological mechanisms.
Miller, R. Crapo, J. Casaburi, et al. General considerations for lung function testing. Van Schalkwyk, C. Schultz, J. Joubert, N. Guideline for office spirometry in adults, S Afr Med J, 94 , pp. Doyma, , pp. Jensen, J. Teeter, R. England, H. Howell, H. White, E. Pickering, et al. Sources of long-term variability in measurements of lung function: implications for interpretation and clinical trial design. Enright, K. Beck, D. Repeatability of spirometry in 18, adult patients.
Steenbruggen, S. Mitchell, T. Severin, P. Eur Respir J, 37 , pp. Parker, T. Dillard, Y. Arm span—height relationships in patients referred for spirometry. Verrall, J. Julian, D. Muir, A. J Occup Med, 31 , pp.
- Starhawk: Academy - Book 7.
- Subscribe to our newsletter.
- The Pale Lady (Fantasy and Horror Classics)?
Chavesse, P. Johnson, J. Francis, I. Balfour-Lynn, M. Rosenthal, A. To clip or not to clip? Nose clips for spirometry. Eur Respir J, 21 , pp. Prandi, J. Dependence of maximal flow-volume curves on time course preceding inspiration. J Appl Physiol, 75 , pp.
Beydon, S. Davis, E. Lombardi, J. Allen, H. Arets, P. Aurora, et al.
- Middle East Up- Rising and repercussions?
- zcdyosd.tk Ebooks and Manuals;
- Descripción general!
- Le Janitor - tome 2 - Week-end à Davos (French Edition)!
Arets, H. Brackel, C. Eur Respir J, 18 , pp. Spirometry quality-control strategies in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care, 53 , pp. Respiratory health. Spirometry procedures manual. Centers for Disease Control and Prevention, ,. Enright, G. Skloot, J. Cox-Ganser, I. Udasin, R. Respir Care, 55 , pp. Pellegrino, G. Viegi, P. Enright, V. Brusasco, R. Crapo, F. Burgos, et al.
Interpretative strategies for lung function tests. Casan, J. Roca, J. Spirometric response to a bronchodilator. Reference values for healthy children and adolescents. Bull Eur Physiopathol Respir, 19 , pp. Castellsaguer, F. Burgos, J. Prediction equations for forced spirometry from European origin population.
Respir Med, 92 , pp. Pino, A. Dorgham, A. Alonso, J. Spirometric reference equations for European females and males aged 65—85 yrs. Eur Respir J, 24 , pp. Quanjer, S. Stanojevic, T. Cole, X. Baur, G. Hall, B. Culver, et al. Multi-ethnic reference values for spirometry for the 3—95 year age range: the global lung function equations. Eur Respir J, 40 , pp.
Vaz Fragoso, T. Gill, G. McAvay, P. Yaggi, J. Use of lambda-mu-sigma-derived Z score for evaluating respiratory impairment in middle-aged persons. Respir Care, 56 , pp. Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function. Mohanka, K. McCarthy, M. Xu, J. A survey of practices of pulmonary function interpretation in laboratories in Northeast Ohio.
How should the lower limit of the normal range be defined?. Respir Care, 57 , pp. Schermer, I. Smeele, B. Thoonen, A. Lucas, J. Grootens, T. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J, 32 , pp. Vollmer, T. Burney, P. Gulsvik, A. Kocabase, et al. Eur Respir J, 34 , pp. Dis Mon, 34 , pp. Bon, J. Weissfeld, F. Kanner, A. Renzetti, W. Stanish, H. Barkman, M. Predictors of survival in subjects with chronic airflow limitation. Am J Med, 74 , pp. Anthonisen, E. Wright, J. Prognosis in chronic obstructive pulmonary disease.
Am Rev Respir Dis, , pp. Aaron, R. Dales, P. How accurate is spirometry at predicting restrictive pulmonary impairment?. Glady, S. Aaron, M. Lunau, J. Clinch, R. A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory. Hong, S. Ra, T. Shim, C. Lim, Y. Koh, S. Lee, et al. Respirology, 13 , pp. Aggarwal, R. Respirology, 12 , pp. Burrows, M. Lebowitz, A. Camilli, R. Longitudinal changes in forced expiratory volume in one second in adults. Methodologic considerations and findings in healthy nonsmokers. Spencer, T. Marshall, P.
Weller, J. A superior method of assessing the reproducibility of pulmonary function measurements. Miller, O. Peak flow meter resistance decreases peak expiratory flow in subjects with COPD. J Appl Physiol, 89 , pp. Pulmonary function laboratory management and procedure manual, Bronchial Reversibility Test.
Brand, Ph. Quanjer, D. Postma, H. Kerstjens, G. Koeter, P. Dekhuijzen, et al. Interpretation of bronchodilator response in patients with obstructive airways disease. Thorax, 47 , pp. Calverley, P. Burge, S. Spencer, J. Anderson, P. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax, 58 , pp. Guyatt, M.
Townsend, S. Nogradi, S. Pugsley, J. Keller, M. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med, , pp. Hanania, A. Sharafkhaneh, B. Celli, M. Decramer, T. Lystig, S. Kesten, et al. Respir Res, 12 , pp. Mendella, J. Manfreda, C. Warren, N. Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med, 96 , pp. Enright, M. Lebowitz, D. Physiologic measures: pulmonary function tests. Asthma outcome. S9 Medline. Expert panel report-guidelines for diagnosis and management of asthma.
Zibrak, C. Ann Intern Med, , pp. Lim, S. Ang, T. Rossing, E. Ingenito, R. Ingram Jr.. The effects of deep inhalation on maximal expiratory flow during intensive treatment of spontaneous asthmatic episodes. Celli, D. Tashkin, S. Rennard, J. McElhattan, U.
Respir Med, , pp. Burge, M. Harries, E. Comparison of atropine with ipratropium bromide in patients with reversible airways obstruction unresponsive to salbutamol. Br J Dis Chest, 74 , pp. Ruffin, J. Fitzgerald, A. A comparison of the bronchodilator activity of Sch and salbutamol. J Allergy Clin Immunol, 59 , pp. Anticholinergic bronchodilators for adult obstructive airways disease.
Am J Med, 91 , pp. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An day multicenter trial. Gross, D. Tashkin, R. Oren, E. Coleman, S. Inhalation by nebulization of albuterol-ipratropium combination Dey combination is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group. Respiration, 65 , pp. Smith, C.
Irvin, R. The utility of spirometry in the diagnosis of reversible airways obstruction. Eiser, C. Phillips, P. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?. Respir Med, 95 , pp. Rodriguez-Carballeira, J. Heredia, L. Gomez, S. Quintana, C. Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther, 12 , pp. Criteria for the assessment of reversibility in airways obstruction.
Chest, 65 , pp. Eliasson, A. Degraff Jr.. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables. Tweeddale, F. Alexander, G. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax, 42 , pp. Sourk, K. Bronchodilator testing: confidence intervals derived from placebo inhalations. Kainu, A. Lindqvist, S. Sarna, B. Lundback, A. FEV1 response to bronchodilation in an adult urban population.
Tashkin, B. Decramer, D. Liu, D. Burkhart, C. Cassino, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J, 31 , pp. Han, R. Wise, J. Mumford, F. Sciurba, G. Criner, J. Curtis, et al. Prevalence and clinical correlates of broncho-reversibility in severe emphysema. Eur Respir J, 35 , pp. Hughes, M. Tobin, D. Bellamy, D. Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema. Thorax, 37 , pp. Martinez, M. Whyte, J. Stetz, S. Gay, B. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function.
Lam, K. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Care Med. Arch Bronconeumol, 45 , pp. Dekker, A. Schrier, P. Sterk, J. Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Pellegrino, J. Rodarte, V. Assessing the reversibility of airway obstruction.
Clinical Trials Register
Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful?. Boggs, K. Bhat, W. Vekovius, M. Ann Allergy, 48 , pp. Berger, D. Acute postbronchodilator changes in pulmonary function parameters in patients with chronic airways obstruction. Chest, 93 , pp. McCormack, P. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. Izquierdo, J. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses.
Vestbo, L. Edwards, P.
ucasiky.tk Ebooks and Manuals
Scanlon, J. Yates, A. Agusti, P. Bakke, et al. Changes in forced expiratory volume in 1 second overtime in COPD. Boushey, P. Enright, J. Spirometry for chronic obstructive pulmonary disease case finding in primary care?. Hueto, P. Cebollero, I. Pascal, J. Cascante, V. Teruel, et al. Arch Bronconeumol, 42 , pp. Johns, D. Burton, J. Walters, R. National survey of spirometer ownership and usage in general practice in Australia.
Respirology, 11 , pp. Should we use spirometry in the early detection of COPD?. Does screening for COPD by primary care physicians have the potential to cause more harm than good?. Han, M. Kim, R. Mardon, P. Renner, S. Sullivan, G. Diette, et al. Liistro, C. Vanwelde, W. Vincken, J. Vandevoorde, G. Verleden, J. Technical and functional assessment of 10 office spirometers: a multicenter comparative study. Derom, C. Liistro, J. Buffels, T. Schermer, E. Lammerse, et al. Clin Chest Med, 22 , pp. Swanney, R. Jensen, D. Crichton, L. Beckert, L. Cardno, R. FEV 6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction.
Eaton, S. Withy, J. Garrett, J. Mercer, R. Whitlock, H. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Levy, Ph. Quanjer, R. Booker, B. Cooper, S. Holmes, I. Diagnostic spirometry in primary care: proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations.
Prim Care Respir J, 18 , pp. Wanger, C. Office spirometry: equipment selection and training of staff in the private practice setting. J Asthma, 34 , pp. Gardner, R. Crapo, B. Jackson, R. This book is not yet featured on Listopia. Community Reviews. Showing Rating details. More filters. Sort order. Well-written book on PFT interpretation. It's easy to read, starts with the basics, and builds on them throughout the book. It's easy to find the information you need, and the explanations are clear. Merima Smajic rated it really liked it Oct 19, Brent Woodson rated it it was amazing Oct 27, Karen Calhoun rated it it was amazing Oct 21, Rgauthie rated it it was amazing Jul 06, Andrea Braun rated it it was amazing Apr 09, Andhika Hutama added it Feb 10, Mukhammad Irkhas marked it as to-read Feb 10, Lucky Alma marked it as to-read Feb 10, Harris Memorial added it Mar 04, Manojm Arya marked it as to-read Dec 04, Andhika Hutama marked it as to-read Jan 21, Milan Modi marked it as to-read Aug 07, Suchithakamath added it May 29, Badr Al-Amir marked it as to-read Jan 22, Radhakrishna Panicker marked it as to-read May 05, Dr U marked it as to-read May 22, Faseed marked it as to-read Jun 26, Eric added it Sep 23, Kashif Aslam marked it as to-read Dec 04, Betty added it Feb 23, Sumedha Narula marked it as to-read Apr 15, Ashvanee Kumar marked it as to-read Sep 14, Tom Ado marked it as to-read Sep 27, James Chew added it Nov 03, Partha Sarathi marked it as to-read Jan 12, Deborah Fertakis marked it as to-read Jan 28, Com marked it as to-read Feb 08,